Artificial intelligence risk prediction model for common respiratory pathogens in China based on heterogeneous multi-source clinical and geographic data: A modeling study.

Publication date: Jul 01, 2026

Most respiratory pathogens exhibit distinct seasonal and periodic outbreak patterns driven by climatic factors. However, predictive models that jointly consider climate, air quality index (AQI), and socioeconomic variables are lacking. We retrospectively analyzed targeted or metagenomic next-generation sequencing data from 153,544 respiratory samples collected from 1,880 centers across 30 provinces in China between September 2022 and September 2024. Monthly positivity rates were matched with geographic, climatic, AQI, and GDP data. CO(0. 098 +/- 0. 016), HCHO(0. 096 +/- 0. 021), O3(0. 102 +/- 0. 019), sunshine hours(0. 103 +/- 0. 028), wind speed(0. 114 +/- 0. 024), and GDP(0. 095 +/- 0. 019). were identified as the key geographical factors for the positivity across most respiratory pathogens via mean Gini index reduction, and a gradient boosting decision tree(GBDT) model was trained and benchmarked against other AI methods using the DISO metric. This model accurately simulated the epidemiological trends from September 2022 to September 2024 and outperformed alternative models with the lowest DISO metric of 0. 12 in influenza A, 0. 21 in SARS-CoV-2, 0. 25 in RSV. The GBDT model was used to predict the short-term epidemic of 10 respiratory pathogens between October and December 2024. The predictions showed consistent trends with the external validation cohort for RNA viruses including SARS-CoV-2 and influenza A virus, but differed for bacterial pathogens. Integrating air quality, climatic, and socioeconomic data yields robust predictions of respiratory infection dynamics in the short-term by the GBDT model, bolstering public health surveillance and offering a framework potentially applicable to other infectious diseases.

Open Access PDF

Concepts Keywords
Air
Aqi
China
Climatic
Data
Diso
Factors
Geographic
Index
Models
Pathogens
Positivity
Respiratory
September
Socioeconomic

Semantics

Type Source Name
drug DRUGBANK Medical air
drug DRUGBANK Flunarizine
pathway KEGG Influenza A
drug DRUGBANK Influenza A virus
disease MESH infectious diseases
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH Emergency
disease MESH Infection
disease MESH influenza
disease MESH respiratory infections
disease MESH hos
disease MESH COVID 19 pandemic
drug DRUGBANK Indoleacetic acid
pathway REACTOME Infectious disease
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH included
disease MESH coinfection
drug DRUGBANK Formaldehyde
disease MESH bacterial infections
disease MESH viral infections
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH parainfluenza
disease MESH MAE
drug DRUGBANK Tretamine
disease MESH pleural effusion
drug DRUGBANK Enterococcus faecium
disease MESH pertussis
pathway KEGG Pertussis
disease MESH PRDS
drug DRUGBANK Trestolone
disease MESH otitis media
disease MESH Dis
drug DRUGBANK Gold
disease MESH community acquired pneumonia
disease MESH Park
drug DRUGBANK Lauric Acid
disease MESH avian influenza

Original Article

(Visited 9 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *